Since TFPI2 has been identified as an early detection marker of CRC, growing evidence has suggested this gene as a potential biomarker in other types of cancer, such as gastric [63] lung [64], pancreas [65], oral [66], esophageal [67], and liver cancer [68]. Here, TFPI2 is linked to cancer.